Runwal Enterprises IPO: ₹500 Cr Fresh Issue, Price Band ₹290–305, GMP, Dates & Review
Runwal Enterprises Ltd, the Mumbai-focused real estate developer of the Runwal Group, opened its ₹499.83 crore initial public offering for subscription on 25 September 2026. The issue is a 100% fresh issue of equity shares — no offer for sale — with the price band fixed at ₹290–305 per share. Bidding closes on 29 September, with allotment expected on 30 September and listing on 5 October 2026 on the BSE and NSE.
Here is everything the red herring prospectus (RHP) and first-day bidding data tell us — the business, the financials, where the money goes, and how the market is receiving it.
Runwal Enterprises IPO: Key Details
| Company | Runwal Enterprises Ltd |
| Total issue size | Up to ₹499.83 crore |
| Issue type | Fresh issue only (no OFS) — ~1.64 crore equity shares |
| Price band | ₹290–305 per share (face value ₹2) |
| Lot size | 49 shares |
| Minimum retail investment | ₹14,945 (49 shares at the upper band) |
| Employee discount | ₹14 per share |
| Subscription dates | 25–29 September 2026 |
| Allotment date | 30 September 2026 (tentative) |
| Refund initiation / share credit | 1 October 2026 (tentative) |
| Listing date | 5 October 2026, on BSE and NSE (tentative) |
| Anchor investment | ₹148.95 crore raised ahead of opening |
| Book running lead managers | ICICI Securities, Jefferies India |
| Registrar | MUFG Intime India |
| RHP filed | 21 September 2026 |
Notably, the issue is smaller than originally planned — the company trimmed its fresh issue from ₹1,000 crore (per its draft papers) to roughly ₹500 crore.
Day 1 Subscription: 0.42x, Led by QIBs
The IPO was subscribed 0.42 times overall on its first day of bidding (25 September), according to exchange data:
| QIB (institutional) | 0.96x |
| Non-institutional (NII/HNI) | 0.28x |
| Retail | 0.18x |
| Employee | 0.17x |
| Total | 0.42x |
Institutional demand carried the opening — QIBs were nearly fully subscribed on day one, while retail and HNI participation was muted, leaving room to build over the remaining bidding window (the issue closes 29 September; note there is no bidding on the weekend in between).
GMP: What the Grey Market Signals
Market-reported grey market data put the Runwal Enterprises IPO premium at around ₹25 per share as of the evening of 25 September, implying a potential listing price of about ₹330 against the ₹305 upper band — an expected listing gain of roughly 8.2%.
Grey market premiums are unofficial, market-reported figures that change constantly and may not reflect actual listing performance. Treat them as sentiment indicators, not predictions.
What Does Runwal Enterprises Do?
Runwal Enterprises is a Mumbai Metropolitan Region-focused real estate developer spanning the full spectrum of development — residential projects across affordable, mid-income and luxury segments, plus commercial spaces, retail malls and educational buildings. The business is anchored by promoter Subodh Subhash Runwal, who has over 31 years of real estate experience.
Scale and market position (per the RHP and industry data cited in it):
- 19 completed, 28 ongoing and 33 upcoming projects, with a total developable area of approximately 88.37 million sq. ft as of 31 March 2026.
- Ranked third in the Mumbai region for new launches and sales between January 2023 and March 2026, and first in sales in Mumbai's eastern suburbs and in new launches in Kalyan-Dombivli.
- Known for large integrated township projects — notably Runwal Gardens and Runwal My City, each spanning around 250 acres and combining residential, educational, commercial and recreational facilities.
Runwal Enterprises Financials
The RHP shows a sharp rebound in FY26 after a weak FY25 — a pattern investors should read carefully, since real estate revenues move with project-completion cycles:
| Particulars (₹ crore) | FY24 | FY25 | FY26 |
| Revenue from operations | 2,408.87 | 1,007.77 | 1,798.95 (+78.52%) |
| EBITDA | 201.73 | 180.11 | 349.81 |
| EBITDA margin | 8.37% | 17.87% | 19.44% |
| Profit after tax (PAT) | 93.70 | 55.65 | 185.76 |
| Total assets | 7,079.74 | 8,328.14 | 10,254.50 |
| Net debt / equity (times) | 3.62 | 4.64 | 3.29 |
Key takeaways:
- Revenue jumped 78.52% year-on-year in FY26 to ₹1,798.95 crore, while PAT more than tripled to ₹185.76 crore.
- Margins have improved consistently — EBITDA margin rose from 8.37% in FY24 to 19.44% in FY26.
- The flip side: leverage is high. Net debt stood at about ₹2,778 crore against net worth of roughly ₹845 crore (3.29x), and operating cash flows were negative in all three fiscal years — typical of capital-intensive project development, but worth noting.
Where Will the ₹500 Crore Go?
| Repayment/pre-payment of certain company borrowings | ₹100 crore |
| Investment in subsidiaries (Runwal Residency & Evie Real Estate) for repayment/pre-payment of their borrowings | ₹225 crore |
| Funding future real estate project acquisitions and general corporate purposes | Balance |
Roughly two-thirds of the proceeds go straight toward deleveraging the company and its subsidiaries — this is a balance-sheet-strengthening issue as much as a growth raise.
Valuation and Brokerage Views
At the upper price band of ₹305, the issue values the company at a P/E of about 24.24x on FY26 post-IPO EPS of ₹12.58 (per broker estimates cited in press coverage).
Brokerage houses covering the issue have largely leaned positive: Ajcon Global Services (Subscribe, citing the company's leading position in Mumbai's eastern suburbs, ranked first in sales with ~7.88% market share there), Anand Rathi, SMIFS and Sushil Finance (Subscribe).
Brokerage recommendations are opinions, not guarantees — investors should read the RHP's Risk Factors section before deciding.
Risks Investors Should Watch
- Mumbai concentration — a large share of projects are in the Mumbai region, exposing the company to local demand, price and regulatory swings.
- High indebtedness — consolidated borrowings of roughly ₹2,909 crore as of 31 March 2026 bring repayment obligations and refinancing risk.
- Cyclical, lumpy revenues — FY25's revenue fell more than half from FY24 before rebounding; project-completion timing drives the P&L.
- Execution and approval risk — construction delays or approval hold-ups can raise costs and defer cash flows.
FAQs
What is the Runwal Enterprises IPO price band?
The price band is ₹290–305 per equity share of face value ₹2, with an employee discount of ₹14 per share.
What is the Runwal Enterprises IPO lot size?
One lot is 49 shares. At the upper band of ₹305, the minimum retail investment is ₹14,945.
When does the Runwal Enterprises IPO close?
The IPO closes for subscription on 29 September 2026. Allotment is tentatively scheduled for 30 September, and listing on 5 October 2026 on the BSE and NSE.
Is the Runwal Enterprises IPO a fresh issue or OFS?
It is entirely a fresh issue of about 1.64 crore equity shares aggregating up to ₹499.83 crore. There is no offer for sale — all proceeds go to the company.
What is the GMP of the Runwal Enterprises IPO?
Market-reported grey market premium was around ₹25 per share as of 25 September evening, implying an ~8.2% potential listing gain. GMP is unofficial and changes frequently.
What will Runwal Enterprises use the IPO money for?
About ₹100 crore for repaying its own borrowings, ₹225 crore for debt repayment by subsidiaries Runwal Residency and Evie Real Estate, and the rest for future project acquisitions and general corporate purposes.
Conclusion
The Runwal Enterprises IPO offers exposure to a Mumbai-centric real estate developer at an inflection point: FY26 revenue rebounded 78.5% with PAT tripling to ₹185.76 crore, margins at their best in three years, and day-one bidding led by institutional investors at 0.96x. Two-thirds of the ₹500 crore raise goes to deleveraging — sensible, given 3.29x net debt-to-equity. But this is a concentrated, cyclical, Mumbai-heavy story with lumpy revenues and meaningful execution risk. Watch how retail and HNI subscription builds into the 29 September close, and how the grey market premium holds over the weekend.
For live grey market premiums on all open issues, see our IPO GMP today (27 Sept) roundup, and for allotment dates of recently closed IPOs, see our 28 Sept allotment guide.
Disclaimer: This article is based on the company's red herring prospectus (dated 21 September 2026), exchange subscription data and press coverage. Dates beyond subscription close are tentative. GMP figures are unofficial and subject to change. This article is for information only and is not investment advice.